11:27 AM EDT, 05/10/2024 (MT Newswires) -- Biohaven ( BHVN ) shares were falling past 11% in recent Friday trading after the company reported a Q1 adjusted net loss that missed analysts' estimates.
The biopharmaceutical company reported a Q1 adjusted net loss late Thursday of $1.77 per diluted share, wider than a loss of $0.98 a year earlier.
Two analysts polled by Capital IQ expected a loss of $1.56.
The company didn't report any revenue for the quarter ended March 31, as expected.
Price: 36.71, Change: -4.65, Percent Change: -11.24